← Leaderboards
Daniel F. Heitjan
Columbia University Health Sciences
$4,981,853
Attributed
$5,565,782
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $540K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,565,782 · 7
By mechanism
R01$2,441,012 · 4
P30$2,044,346 · 1
P01$1,080,424 · 2
Top collaborators
- Ian Alexander Blair2 shared
- Eldon R Jupe2 shared
- Richard J Santen2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Edward V Nunes$88,947,598
- Frances Rudnick Levin$39,078,718
- Deborah S. Hasin$40,571,837
- Carlos Blanco$12,631,998
- Denise B Kandel$14,719,404
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsStatistics /BiometryClinical ResearchDesignResearch PersonnelReportingExperimental DesignsBasic ScienceMemberResearch Project GrantsQuality ControlData AnalysesResearch DesignClinical Trials DatabaseAnticancer ResearchCollaborationsBiometryConsultManuscriptsData ManagementCase Report FormGraphPreparationSample Size
Grant awards (28)
Biostatistics & Data Management$97,246
P01 · FY2016 · CA · contact PI
Biostatistics & Data Management$97,246
P01 · FY2015 · CA · contact PI
Biostatistics & Data Management$91,332
P01 · FY2014 · CA · contact PI
Development of Breast Cancer Risk Model Based on Estrogen Metabolomics$335,808
R01 · FY2013 · CA
Biostatistics & Data Management$85,419
P01 · FY2013 · CA · contact PI
Development of Breast Cancer Risk Model Based on Estrogen Metabolomics$442,764
R01 · FY2012 · CA
Biostatistics & Data Management$97,246
P01 · FY2012 · CA · contact PI
Biostatistics and Data Management Core$137,970
P01 · FY2010 · CA · contact PI
Statistical methods in smoking cessation research$231,592
R01 · FY2009 · CA · contact PI
Biostatistics and Data Management Core$133,903
P01 · FY2009 · CA · contact PI
Statistical methods in smoking cessation research$235,558
R01 · FY2008 · CA · contact PI
Biostatistics and Data Management Core$130,954
P01 · FY2008 · CA · contact PI
Statistical methods in smoking cessation research$243,721
R01 · FY2007 · CA · contact PI
Biostatistics and Data Management Core$132,474
P01 · FY2007 · CA · contact PI
Biostatistics and Data Management Core$76,634
P01 · FY2006 · CA · contact PI
Measuring Sensitivity to Nonignorability$192,221
R01 · FY2003 · HL
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2002 · CA
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2002 · CA
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2002 · CA
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2002 · CA
Measuring Sensitivity to Nonignorability$192,221
R01 · FY2002 · HL
CLINICAL TRIALS AND OUTCOMES RESEARCH$112,971
R01 · FY2002 · HL
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2001 · CA
Measuring Sensitivity to Nonignorability$198,406
R01 · FY2001 · HL
CLINICAL TRIALS AND OUTCOMES RESEARCH$127,875
R01 · FY2001 · HL
CORE--BIOSTATISTICS FACILITY$296,752
P30 · FY2000 · CA
CORE--BIOSTATISTICS FACILITY$263,834
P30 · FY2000 · CA
CLINICAL TRIALS AND OUTCOMES RESEARCH$127,875
R01 · FY2000 · HL